VAV2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.470000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.791570E-01
Normal-vs-Stage2
7.708400E-01
Normal-vs-Stage3
4.071400E-01
Normal-vs-Stage4
4.517000E-01
Stage1-vs-Stage2
1.152780E-01
Stage1-vs-Stage3
7.128800E-01
Stage1-vs-Stage4
5.302600E-01
Stage2-vs-Stage3
3.975400E-01
Stage2-vs-Stage4
5.588600E-01
Stage3-vs-Stage4
8.465000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.378200E-01
Normal-vs-AfricanAmerican
9.498400E-01
Normal-vs-Asian
7.220600E-01
Caucasian-vs-AfricanAmerican
7.020800E-01
Caucasian-vs-Asian
8.675600E-01
AfricanAmerican-vs-Asian
6.286800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.384200E-01
Normal-vs-Female
9.541600E-01
Male-vs-Female
3.601600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.865220E-01
Normal-vs-Age(41-60Yrs)
7.134800E-01
Normal-vs-Age(61-80Yrs)
5.963200E-01
Normal-vs-Age(81-100Yrs)
9.666400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.592200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.146200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.837800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.659900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.532400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.784800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.229000E-01
Normal-vs-Daily Drinker
9.541600E-01
Normal-vs-Weekly Drinker
4.570800E-01
Normal-vs-Occasional Drinker
8.729600E-01
Normal-vs-Social Drinker
5.896800E-01
Non Drinker-vs-Daily Drinker
4.722200E-01
Non Drinker-vs-Weekly Drinker
9.223200E-01
Non Drinker-vs-Occasional Drinker
3.066200E-01
Non Drinker-vs-Social Drinker
7.402300E-02
Daily Drinker-vs-Weekly Drinker
3.684800E-01
Daily Drinker-vs-Occasional Drinker
6.706800E-01
Daily Drinker-vs-Social Drinker
2.353400E-01
Weekly Drinker-vs-Occasional Drinker
1.979820E-01
Weekly Drinker-vs-Social Drinker
8.903900E-02
Occasional Drinker-vs-Social Drinker
3.508000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.710200E-01
Normal-vs-Grade 2
1.201390E-01
Normal-vs-Grade 3
1.063750E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.207200E-01
Grade 1-vs-Grade 3
6.413400E-01
Grade 1-vs-Grade 4
3.710200E-01
Grade 2-vs-Grade 3
1.053750E-01
Grade 2-vs-Grade 4
1.201390E-01
Grade 3-vs-Grade 4
1.063750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.736200E-01
Normal-vs-NonDiabetic
9.733800E-01
Diabetic-vs-NonDiabetic
3.315800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.807200E-01
Normal-vs-NoPancreatitis
8.610000E-01
Pancreatitis-vs-NoPancreatitis
6.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.998600E-01
Normal-vs-N1
7.686600E-01
N0-vs-N1
4.824400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.119400E-01
Normal-vs-TP53-NonMutant
9.303800E-01
TP53-Mutant-vs-TP53-NonMutant
2.101500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
